Please login to the form below

Not currently logged in
Email:
Password:

Janssen’s UK head moves to China

Cesar Rodriguez appointed managing director of Xian Janssen
Janssen Cesar Rodriguez.

Janssen's managing director for the UK and Ireland has moved to a new role in China.

Cesar Rodriguez has been named managing director and president of Xian Janssen, the Chinese subsidiary of Johnson & Johnson's pharma division Janssen.

The move marks another step in a well-travelled career for Rodriguez, which includes spells in Spain, Romania and, during the Arab Spring, Egypt.

At his most recent role in the UK, Rodriguez's significant accomplishments included leading Janssen as the top-ranked pharma company in The Sunday Times' Best Companies To Work For in 2012 and achieving a 100 per cent success rate with NICE in 2013.

The company also won The Accenture Award for PMEA Company of the Year at PMEA 2013 last week.

Kim Taylor, company group chairman, Janssen Pharmaceuticals, Asia Pacific, praised the experience of Rodriguez.

She said: “With almost two decades of work experience at Janssen in various commercial and senior leadership roles, Cesar will bring to the company in-depth understanding and insights on business strategy, a track record of delivering business growth in highly complex and diverse markets, and a career-long commitment to integrity and talent development.”

Rodriguez said he was looking forward to the challenges offered by a new market.

He said: “China faces tremendous unmet medical need, and I am excited to be joining Xian Janssen at a time when we are in an unparalleled position to serve that need and to bring important life-saving drugs to patients and families who need them.”

5th December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...